Free shipping on all orders over $ 500

 About 1 result found for searched term "1362509-93-0" (0.127 seconds)

Cat.No.  Name Target
M24629 Idarucizumab Others
BI 655075
Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.